Ignite Creation Date:
2024-05-06 @ 8:25 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02735850
Status:
WITHDRAWN
Last Update Posted:
2017-05-23
First Post:
2016-03-22
Brief Title:
Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer ImmunoSABR
Sponsor:
Maastricht Radiation Oncology
Organization:
Maastricht Radiation Oncology
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Limited Metastatic Disease |
| NSCLC Stage IV |
Keywords: